The incidence of immune checkpoint inhibitors (ICI)-related hepatitis is 5% to 30%,[9,10] which is mainly manifested by an increase in alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) with or without bilirubin. Here, GPT is linked to Hepatitis.